Long Non-Coding RNA MIR4435-2HG Promotes Glycolysis and Tumor Immunity in Pancreatic Cancer Through Absorption of microRNA-582-5p to Target GPX8

Objective: Long non-coding RNA MIR4435-2HG (MIR4435-2HG) has been clarified as a promoter in cancers, but its involvement in pancreatic cancer (PC) was not thoroughly probed. Methods MIR4435-2HG levels in PC clinical tissue and cell lines were analyzed. The relation between MIR4435-2HG levels with clinicopathological characteristics and survival of PC patients was evaluated. After transfection with plasmids altering MIR4435-2HG, microRNA (miR)-582-5p or glutathione peroxidase-8 (GPX8), the biological functions, glycolysis and tumor immunity of PANC-1 cells were observed. In vivo tumor growth was observed in nude mice. Results MIR4435-2HG was highly expressed in PC tissues and cell lines which was negatively correlated with clinicopathological characteristics and prognosis of PC patients. MIR4435-2HG or GPX8 inhibition or miR-582-5p elevation restrained the growth, glycolysis and immunity of PANC-1 cells. miR-582-5p down-regulation or GPX8 up-regulation reversed the effect of silenced MIR4435-2HG on PANC-1 cells. In vivo experiments further confirmed the in vitro results. Conclusion Our study highlights that MIR4435-2HG promotes glycolysis and tumor immunity in PC through absorption of micR-582-5p to target GPX8.